课题基金 / 基金详情

HIV VACCINE PRODUCTION

HIV VACCINE PRODUCTION
HIV疫苗生产
批准号：
6214442
负责人：
Phillip Wayne Berman
金额：
$0.0万
依托单位：
VAXGEN, INC.
依托单位国家：
美国
项目类别：
财政年份：
1999
资助国家：
美国
项目状态：
已结题
起止时间：
1999-07-09 至 2000-07-08
来源：
https://reporter.nih.gov/project-details/6214442
关键词：
AIDS vaccines biomedical facility drug screening /evaluation human immunodeficiency virus 1 vaccine development

项目摘要

项目成果

Phillip Wayne Berman的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The objective of this contract is to produce, scale-up, characterize and formulate reagent grade (GLP) and /or clinical grade (cGMP) HIV-1recombinant subunit vaccine products for animal and/or human trials. For clinical grade materials the manufacturer must perform all required vaccine lot characterization tests. The contractor must also work together with other contractors performing safety and immunogenicity testing of the vaccine product or producing FDA-required documentation in support of an IND.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Re-engineering gp120 to include glycan-dependent epitopes
Re-engineering gp120 to include glycan-dependent epitopes
Enhanced Anti-HIV-1 Antibody Responses in African American Women Seropositive for
Enhanced Anti-HIV-1 Antibody Responses in African American Women Seropositive for
海外基金